// App-Quantinova.ai

P6-05-02 : Estrogen receptor beta repurposes EZH2 to inhibit oncogenic NFκB signaling in triple negative breast cancer

Researchers

Presenter

  • Kirsten GM Aspros

Principal Investigators

  • Adam W Nelson

  • Zhenqing Ye

  • Zhifu Sun

  • Igor Chernukhin

  • Jason S Carroll

  • James N Ingle

  • Matthew P Goetz

  • John R Hawse

Medical Centers

  • Mayo Clinic, Rochester, MN

  • Cambridge Research Institute, Cambridge, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Enhancer of zeste homolog 2

  • Estrogen receptor beta

Drug/Treatment

  • EZH2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved